Cerevel Therapeutics Hldg (NASDAQ:CERE) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.41) by 2.44 percent. This is a 48.15 percent decrease over losses of $(0.27) per share from the same period last year.
Dole IPO Drops Over 9% During First Day Of Trading
What happened: Shares of the world’s large produce company slid by over 9% on Friday after debuting on the New York Stock Exchange. Dole (NYSE: DOLE) opened for trading at $15, at an implied market value of approximately $1.5 billion, which was below the initial public offering of $16.
